J. Hreiki

Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors.

V. Vacic, N. Schultz, M. Berger, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genomic characterization of response to chemoradiation in urothelial bladder cancer

M. Berger, M. Zelefsky, I. Ostrovnaya, 2016, Cancer.

Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer

B. Taylor, A. Viale, M. Berger, 2016, Nature Genetics.

First-in-Human Trial of the Oral Ataxia Telangiectasia and Rad3-Related Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors.

Y. Drew, R. Plummer, A. Schlicker, 2020, Cancer discovery.

First-in-human trial of the oral ataxia telangiectasia and Rad3-related (ATR) inhibitor BAY 1895344 in patients (pts) with advanced solid tumors.

B. Goh, F. Meric-Bernstam, D. Hong, 2019, Journal of Clinical Oncology.

Methimazole-induced myositis: a case report and review of the literature

G. Abdallah, S. Sissi, J. Hreiki, 2013, Endocrinology, diabetes & metabolism case reports.